List of Excipients in API azelastine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing azelastine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | BENZALKONIUM CHLORIDE | |
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | EDETATE DISODIUM | |
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | HYPROMELLOSES | |
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | SODIUM CITRATE | |
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | SORBITOL | |
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | SUCRALOSE | |
| Bayer HealthCare LLC | ASTEPRO ALLERGY | azelastine hcl | 0280-0065 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing azelastine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| AvKARE | azelastine | 42291-094 | ANHYDROUS CITRIC ACID |
| AvKARE | azelastine | 42291-094 | BENZALKONIUM CHLORIDE |
| AvKARE | azelastine | 42291-094 | EDETATE DISODIUM |
| AvKARE | azelastine | 42291-094 | HYPROMELLOSES |
| AvKARE | azelastine | 42291-094 | SODIUM CHLORIDE |
| AvKARE | azelastine | 42291-094 | SODIUM PHOSPHATE |
| AvKARE | azelastine | 42291-094 | WATER |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for azelastine
Excipient focus: ANHYDROUS CITRIC ACID
azelastine drug variants containing ANHYDROUS CITRIC ACID
azelastine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZALKONIUM CHLORIDE
azelastine drug variants containing BENZALKONIUM CHLORIDE
azelastine drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
azelastine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
azelastine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
azelastine drug variants containing CELLULOSE, MICROCRYSTALLINE
azelastine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID
azelastine drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | azelastine hydrochloride | 50090-7461 |
| >Company | >Ingredient | >NDC |
azelastine drug variants not containing CITRIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
azelastine drug variants containing CITRIC ACID MONOHYDRATE
azelastine drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: DISODIUM PHOSPHATE
azelastine drug variants containing DISODIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | azelastine hydrochloride | 50090-2330 |
| >Company | >Ingredient | >NDC |
azelastine drug variants not containing DISODIUM PHOSPHATE
Excipient focus: EDETATE DISODIUM
azelastine drug variants containing EDETATE DISODIUM
azelastine drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Wallace Pharmaceuticals Inc | azelastine hydrochloride | 51525-0294 |
| Physicians Total Care Inc | azelastine hydrochloride | 54868-5072 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
azelastine drug variants containing GLYCERIN
azelastine drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
azelastine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | azelastine | 69238-2147 |
| Amneal Pharmaceuticals LLC | azelastine hydrochloride | 65162-706 |
| >Company | >Ingredient | >NDC |
azelastine drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
azelastine drug variants containing HYPROMELLOSE
azelastine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
azelastine drug variants containing HYPROMELLOSE 2910
azelastine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
azelastine drug variants containing HYPROMELLOSES
azelastine drug variants not containing HYPROMELLOSES
Excipient focus: PHENYLETHYL ALCOHOL
azelastine drug variants containing PHENYLETHYL ALCOHOL
azelastine drug variants not containing PHENYLETHYL ALCOHOL
Excipient focus: POLYSORBATE 80
azelastine drug variants containing POLYSORBATE 80
azelastine drug variants not containing POLYSORBATE 80
Excipient focus: SODIUM CHLORIDE
azelastine drug variants containing SODIUM CHLORIDE
azelastine drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
azelastine drug variants containing SODIUM CITRATE
azelastine drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
azelastine drug variants containing SODIUM HYDROXIDE
azelastine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE
azelastine drug variants containing SODIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | azelastine | 42291-094 |
| A-S Medication Solutions | azelastine | 50090-3833 |
| Amneal Pharmaceuticals LLC | azelastine | 65162-676 |
| >Company | >Ingredient | >NDC |
azelastine drug variants not containing SODIUM PHOSPHATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
azelastine drug variants containing SODIUM PHOSPHATE, DIBASIC
azelastine drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE
azelastine drug variants containing SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | azelastine hydrochloride | 59651-214 |
| NorthStar Rx LLC | azelastine hydrochloride | 72603-611 |
| >Company | >Ingredient | >NDC |
azelastine drug variants not containing SODIUM PHOSPHATE, DIBASIC DODECAHYDRATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
azelastine drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
azelastine drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
azelastine drug variants containing SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
azelastine drug variants not containing SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
azelastine drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
azelastine drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Excipient focus: SORBITOL
azelastine drug variants containing SORBITOL
azelastine drug variants not containing SORBITOL
Excipient focus: SUCRALOSE
azelastine drug variants containing SUCRALOSE
azelastine drug variants not containing SUCRALOSE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
azelastine drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | azelastine hydrochloride | 50383-942 |
| Aurohealth LLC | azelastine hydrochloride | 58602-020 |
| Aurobindo Pharma Limited | azelastine hydrochloride | 59651-215 |
| >Company | >Ingredient | >NDC |
azelastine drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
azelastine drug variants containing WATER
azelastine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Wallace Pharmaceuticals Inc | azelastine hydrochloride | 51525-0294 |
| Physicians Total Care Inc | azelastine hydrochloride | 54868-5072 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links